This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Source-linked TEP1 Western blot protocol options, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-TEP1 WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, source-linked protocol options, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~290.5 kDa | |
| Gel | 4–12% gradient (standard starting point) | |
| Negative control | Suggested KO / knockdown lysate |
| PTM | — | |
| Caveat | — | |
| Gene-set association | MSigDB C7 membership | |
| Isoform | 2 isoform(s) |
The A02017 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.
| Sample / lysate | human kidney tissue lysate (catalog A02017) |
| Gel % | 4–12% gradient (standard starting point) |
| Load | 20–30 µg total protein per lane; optimize for abundance (standard starting point) |
| Transfer | Wet/tank transfer; optimize duration (standard starting point) |
| Membrane | 0.45 µm PVDF (standard starting point) |
| Blocking | 5% milk or 5% BSA in TBST (standard starting point) |
| Primary antibody | A02017 · (A) 0.5 and (B) 1 μg/mL (catalog A02017) |
| Primary incubation | Overnight at 4 °C (standard starting point) |
| Secondary antibody | Species-matched HRP conjugate at validated dilution (standard starting point) |
| Secondary incubation | 1 h at room temperature (standard starting point) |
| Wash | 3 × 5 min in TBST (standard starting point) |
| Detection | ECL; bracket exposures to avoid saturation (standard starting point) |
TEP1 is predicted at 290.5 kDa; alternative splicing may affect size, but no empirical migration or distinct isoform bands are demonstrated.
| Band near 290.5 kDa | Consistent with the predicted TEP1 mass; confirm identity with controls |
| Single band at another size | Migration alone cannot establish TEP1 identity or an isoform assignment |
| Two bands at different sizes | Isoforms 1 and 2 exist, but their migration difference is unknown |
| Band enriched in a nuclear fraction | Consistent with TEP1's nuclear location; confirm identity with controls |
| Predicted TEP1 mass | Provides a 290.5 kDa reference, not a measured migration position |
| Isoform 1 | Its separate mass and migration are not supplied |
| Isoform 2 | Its separate mass and migration are not supplied |
| Alternative splicing | May affect protein size, but distinct bands are not established |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | Nuclear TEP1 may be difficult to detect in whole-cell lysate | Check a nuclear fraction and a validated positive control |
| Band higher than expected | The band cannot be assigned to TEP1 by size alone | Check antibody specificity with a TEP1-depleted sample |
| Band lower than expected | An isoform assignment cannot be made without isoform sizes | Compare with a TEP1-depleted sample and an isoform-specific control if available |
| Multiple bands | Alternative splicing is documented, but distinct isoform bands are not established | Identify TEP1-dependent bands with a depletion control |
| Weak or no signal | The nuclear target may be diluted in whole-cell lysate | Enrich the nuclear fraction and check a validated positive control |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| No high/medium HPA tissues identified in the supplied evidence. | ||||
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| No lower-expression tissue rows available in the supplied evidence. | ||||
Deeper troubleshooting and optimisation questions for TEP1, answered from its protein features.
Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.
the supplier A02017 is an anti-TEP1 antibody listed for human, mouse, and rat. Its Western blot image shows human kidney tissue lysate tested at 0.5 and 1 μg/mL; the supplied evidence does not show mouse or rat blots.
Which to pick: A02017 is the only listed option. Its Western blot image supports use in the reported human kidney lysate conditions; mouse and rat reactivity is listed but not shown in the supplied image.